ciclesonide

06/01/2001 - "Ciclesonide significantly improved asthma control. "
05/01/2012 - "Clinical efficacy studies suggest that Ciclesonide is superior to placebo and is at least as effective as several active comparators with an improved therapeutic margin thereby improving the therapeutic outcome in patients of asthma."
01/01/2008 - "Lots of clinical trials show that ciclesonide is effective in asthma control in a wide range of doses from 40 do 1280 mug/day in a dose-dependent manner. "
01/01/2008 - "Inhaled ciclesonide delivered by HFA-MDI is effective in the prophylactic treatment of persistent asthma in adults, adolescents and children, and is generally well tolerated. "
07/01/2007 - "Once-daily administration of ciclesonide at doses of 100, 200 or 400 microg was shown to be effective in adult patients with mild to moderate asthma. "

10/01/1999 - "The results of this study clearly indicate that the new topical steroid ciclesonide is effective in the treatment of allergic rhinitis without producing local or systemic side effects."
10/01/1999 - "The new topical steroid ciclesonide is effective in the treatment of allergic rhinitis."
10/01/1999 - "A randomized, placebo-controlled, double-blind crossover study was performed to investigate the efficacy of ciclesonide nasal spray in allergic rhinitis at the dose level of 200 micrograms per nostril. "
12/01/2010 - "A hypotonic aqueous nasal spray of ciclesonide is indicated for the treatment of allergic rhinitis (AR). "
01/01/2009 - "Ciclesonide is an intranasal corticosteroid approved for the treatment of allergic rhinitis (AR). "

04/01/2007 - "The new inhaled steroid ciclesonide is effective in established inflammation, is activated only in the respiratory system, and has negligible systemic effects. "
01/01/2008 - "Ciclesonide treatment inhibits T cell migration and cytokine production upon allergen inhalation, which is regulated independently from reducing CCL17 release, but may contribute to beneficial effects of ciclesonide on Th2-mediated airway inflammation."
09/15/2007 - "To evaluate whether ciclesonide could directly modulate in vitro bronchial fibroblast functions being converted into des-ciclesonide by these pluripotent cells involved in the regulation of airway inflammation and remodelling. "
01/01/2007 - "Ciclesonide is a novel inhaled corticosteroid for the treatment of airway inflammation. "
07/01/2006 - "Ciclesonide has also been shown to improve lung function, to treat the underlying inflammation, to be effective as monotherapy in patients with persistent asthma, to have reduced side effects compared with other ICS, and to be easy to use with once-daily dosing. "

03/01/2015 - "Three individual symptoms of rTNSS, including runny nose, nasal itching, and congestion, were improved in the ciclesonide-treated group. "
12/01/2010 - "In Study 2, although ciclesonide improved the majority of scores compared with fluticasone propionate only 'oropharyngeal itching' reached statistical significance (p < 0.025, one-sided). "

07/01/2007 - "Long-term safety and efficacy of intranasal ciclesonide in adult and adolescent patients with perennial allergic rhinitis."
01/01/2008 - "Similarly, in adolescents and adults with moderately severe perennial allergic rhinitis, ciclesonide 200 microg once daily was more effective than placebo in terms of reducing nasal symptoms in well designed trials of 6 weeks' and 1 year's duration. "
02/01/2007 - "Efficacy and safety of ciclesonide, 200 microg once daily, for the treatment of perennial allergic rhinitis."
07/01/2012 - "A 26-week tolerability study of ciclesonide nasal aerosol in patients with perennial allergic rhinitis."
01/01/2012 - "Efficacy and tolerability study of ciclesonide nasal aerosol in patients with perennial allergic rhinitis."